Immune checkpoint inhibitors as first-line therapy for non-small cell lung cancer: A systematic evaluation and meta-analysis

Immune checkpoint inhibitors as first-line therapy for non-small cell lung cancer: A systematic evaluation and meta-analysis

Recently, immune checkpoint inhibitors (ICIs) present promising application prospects in treating non-small cell lung cancer (NSCLC). This study aimed to investigate optimal treatment strategy by comparing the first-line treatment strategies with ICIs in NSCLC. We retrieved relevant studies on first...

Full description

Bibliographic Details
Main Authors: Yu Lu, Xiaoyan Zhang, Jiyu Ning, Manyan Zhang
Format: Article
Language:English
Published: Taylor & Francis Group 2023-01-01
Series:Human Vaccines & Immunotherapeutics
Subjects:
nsclc
immune checkpoint inhibitor
chemotherapy
first-line therapy
network meta-analysis
Online Access:http://dx.doi.org/10.1080/21645515.2023.2169531

Similar Items

Similar Items